Today's Daily Dose brings you news about Acasti Pharma and AtriCure's stock offering; near-term catalyst of Entasis, Evofem Biosciences, Neon Therapeutics and Seres, and updated results from Sarepta's Phase 1/2a gene therapy clinical trial in DMD.
from RTT - Biotech https://ift.tt/2ye23Yw
via IFTTT
No comments:
Post a Comment